Financials
- Market Capitalization 138.12 M
- Employee 34
- Founded 2004
- CEO Christopher U. Missling Ph.D.
- Website www.anavex.com
- Headquarter New York, United States
- FIGI BBG000C9K8K4
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-16.48
Fiyat/satışlar oranı
174.66
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3686 | CDXS Codexis, Inc. - Common Stock | 1.32 USD | -6.38% | -2.94% | -8.97% | -46.56% | 144.55 M USD | ||
| 3689 | NBP NovaBridge Biosciences - American Depositary Shares | 1.30 USD | -1.52% | -7.14% | -18.24% | -71.18% | 150.00 M USD | ||
| 3710 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.57 USD | -3.39% | 0.00% | -12.31% | +38.18% | 138.77 M USD | ||
| 3716 | IPHA Innate Pharma S.A. - American Depositary Shares | 1.46 USD | -1.35% | -8.18% | -21.51% | -32.41% | 136.83 M USD |